๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Microangiopathy in Patients with Chronic Myelogenous Leukemia Treated with Interferon

โœ Scribed by Andreas Creutzig; Mathias Freund; Ludwig Caspary; Klaus Alexander

Book ID
115640892
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
112 KB
Volume
52
Category
Article
ISSN
0026-2862

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thrombotic microangiopathy associated wi
Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia : Coincidence or true side effect?
โœ Farhad Ravandi-Kashani; Jorge Cortes; Moshe Talpaz; Hagop M. Kantarjian ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 2 views

## BACKGROUND. Interferon-โฃ (rIFN-โฃ) is an established therapy for patients with myeloproliferative disorders. Unusual immune-mediated side effects have been associated with rIFN-โฃ therapy. The association of rIFN-โฃ therapy with hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpu

Cutaneous sarcoidosis in a patient with
Cutaneous sarcoidosis in a patient with philadelphia-positive chronic myelogenous leukemia treated with interferon-ฮฑ
โœ Yavorkovsky, Leonid L.; Carrum, George; Bruce, Suzanne; McCarthy, Philip L. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 17 KB ๐Ÿ‘ 3 views

A patient with Philadelphia-positive (Ph+) chronic myelogenous leukemia (CML) was diagnosed with cutaneous sarcoidosis after treatment with interferon-alpha (IFN-โฃ). Following IFN-โฃ dose reduction, the skin lesions disappeared. Few cases of sarcoidosis associated with IFN treatment have been reporte